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INTRODUCTION
Migraine headache is a common  disabling condition which represents 
a  significant  healthcare  burden.  It  is  characterised  by  recurrent  disabling 
attacks of headache associated with nausea, vomiting, hypersenstivity to light, 
sound, and smell and in a third of patients neurological aura symptoms. These 
aura symptoms are  fully  reversible visual,  sensory or  speech disturbances. 
Visual disturbances are common and last for 5 – 60 mins. The underlying 
neurological mechanism for aura is cortical spreading depression32. 
Recent  evidence  found  a  significant  association  between  patent 
foramen  ovale  and  transient  global  amnesia.  This  finding  prompted  the 
suggestion that paradoxical microembolisation in the vertebrobasilar territory 
may cause transient global amnesia. Like transient global amnesia, migraine 
with visual aura is a paroxysmal disturbance in which a sudden dysfunction of 
cortical areas fed by the terminal branches of the basilar artery is believed to 
trigger the attack. Arteriovenous shunting of vasoactive substances from the 
venous to the arterial system through a patent foramen ovale in patents with 
migraine may affect  endothelial  function (van mokt et  al)45.  In  individuals 
with a right to left shunt, a lower dose of venous trigger substances may be 
needed to induce migraine because the shunt permits the pulmonary filter to 
be bypassed.5,45,49.
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Many studies  have  shown migraineurs  who  experience  an  aura  are 
more likely to have a patent foramen ovale (48%) than the general population 
(20%).  Right  to  left  cardiac  shunt  at  rest  through a  patent  foramen ovale 
(PFO)  is  more  common  in  migraineurs  with  aura  (15%)  than  in  control 
patients  with patent  foramen ovale  who do not experience migraine (0%). 
This  suggest  that  interatrial  communication  may  play  a  role  in  the 
pathogenesis  of  migraines.  Closure  of  patent  foramen  ovale  had  resolved 
symptoms of migraine with aura in 50% of patients and improved symptoms 
in other 50% of subjects  5,29,53.  Many studies have demonstrated closure of 
patent foramen ovale reduce migraine symptoms 3,5,11,14,15,29,37.
 This  study  investigated  the  prevalence  of  cardiac  shunt  lesions  in 
migraine  patients  with  and  without  aura.  The  transesophageal  contrast 
echocardiography  has  been  done  to  detect  intracardiac  shunts  in  migraine 
patients with and without aura.
  
8
AIMS AND OBJECTIVES
1. To evaluate the frequency of cardiac shunt lesions in patients with migraine 
with aura and migraine without aura.
2. To correlate the variables of migraine with variables of shunt.
3. To  compare  the  results  of  our  study with  that  reported  by  other  studies 
performed in various parts of the world.
9
REVIEW OF LITERATURE
Migraine  is  a  common  disabling  primary  headache  disorder. 
Epidemiological studies have documented its high prevalence and high socio 
economic  and  personal  impacts.  It  is  now  ranked  by  the  world  health 
organisation as number 19 among all diseases worldwide causing disability. It 
is estimated that 2,50,000 patients in the U.S. have at least one migraine per 
week,  with  a  lifetime  prevalence  of  18%  .  Migraine  is  a  risk  factor  for 
cryptogenic  stroke,  particularly  in  young  patients  without  artherosclerosis. 
The last 20 years have witnessed a great deal of advances in understanding of 
the pathophysiology, pharmacology, epidemiology and genetics of migraine. 
The  International  headache society  (IHS)  classified  headache into  primary 
headache  disorder  and  secondary  headache  disorder.  Migraine  with  and 
without  aura,  tension  type  headache  and  other  trigeminal  autonomic 
cephalalgias from the majority of primary headache disorders.Migraine is a 
primary  headache  disorder  characterised  by  various  combinations  of 
neurological, gastrointestinal and autonomic changes. The word Migraine is 
derived  from  the  Greek  word  “hemicrania”  (galen,  circa  200  AD).  The 
diagnosis is based on the headache’s characteristics and associated symptoms.
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Differential diagnosis of primary beadacbes
Clinical Tension-type Cluster 
Features Migraine headache headache
Men:women 25:75 40:60 90:10
Lateralisation 60% unilateral Diffuse bilateral 100% unilateral
Location Frontal, periorbital,      Diffuse
Periorbital
temporal,
hemicranial
Frequency            1-4 per month           1-30 per month          1-3 per day for 
3-12 months
Severity           Moderate/severe  Mild/moderate Extremely severe
Duration 4-72 hours Variable 15minutes-
3 hours
Pain character         Throbbing, pulsating  Dull   Sharp, boring
Periodicity         ±      -       +++
Family history                    +++                   ±         ±
Associated symptoms
Aura          +++       -                     -
Autonomic features            ±                   -                   +++
Nausea/vomiting         +++                   -                     ±
Photo/phonophobia          +++       -                     ±
Exacerbation by movement  +++       -                      -
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The International headache society diagnostic criteria for headache disorders 
(1988) 19 have been revised (2004) 2nd edition20 (cephal 2004) First revision 2nd 
edition published in may 2005 - ICHD II R1 43 and describe a total of seven 
sub types of Migraine .
Epidemiology of Migraine
American  Migraine  study  I  conducted  in1989  revealed  that 
approximately 18% women and 6% of men in the united states have migraine, 
resulting  in  an  estimated  23.6  million  Americans  experiencing  migraine. 
Migraine  prevalence  varies  with  the  age,  the  highest  being  found  among 
persons between 35 and 45 years of age. The prevalence of migraine was 
found to be higher in the lowest income group and whites than in blacks. The 
American migraine study II conducted 10 years later had similar prevalence 
estimates  but  estimated  number  of  migraineurs  had  increased  to 
approximately 28 million due to population growth.
Migraine prevalence varies by age, gender, race and income. Before 
puberty,  the  migraine  prevalence approximately  4%.  After  puberty  the 
prevalence  increases  more  rapidly  in  girls  than  boys.  It  increases  until 
approximately  age  40,  then  declines.  The  prevalence  is  similar  in  the 
European countries and in the United states. The prevalence is lowest among 
Asian Americans, intermediate among African Americans and highest among 
white persons.
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MIGRAINE ASSOCIATED DISABILITY
Migraine  substantially  affects  quality  of  life.  The  world  health 
organization  ranks  Migraine  among  the  world’s  most  disabling  medical 
illnesses48.  Approximately  28  million  Americans  have  severe  disabling 
migraine headaches.  Migraine’s annual cost to employers is  approximately 
$13  billion  and  related  annual  medical  costs  exceed  $1  billion.  81%  of 
migraineurs  reported  functional  impairment  with  the  headache  in  the 
American Migraine study II  24.  53% reported that severe  headache caused 
extreme impairment in activities and required bed rest.
Duration  of  Migraine  associated  activity  restrictions  was  greater 
among women migraineurs.  Approximately 31% of all  migraineurs missed 
more than a day of work or school because of Migraine the 3 months prior to 
the survey 24. 51% reported that work or school activity was reduced by more 
than 50%. Household and family or social activities are more likely than work 
or school activity to be disrupted by Migraine. 67% reported that household 
productivity was reduced by more than 50%. Many migraineurs live in fear, 
knowing an  attack  will  disrupt  their  ability  to  work,  to  take care  of  their 
families  or  to  meet  social  obligations.  Health  related  quality  of  life 
measurements have shown that  compared with other chronic illnesses  like 
hypertension,  diabetes,  and  coronary  artery  diseases,  migraine  has  lowest 
scores in physical functioning, bodily pain and other health aspects. Clinically 
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validated  migraine  disability  scales  are  available  for  clinical  use.  These 
include the Migraine disability assessment scale (MIDAS)26, 41  and Headache 
impact scale (HIT)47 .   The data from a population based sample of about 
2000 migraineurs,  50% of migraineurs account  for more than 90% of all 
work loss due to migraine.These finding imply that health care intervention 
should be directed to the most disabled segment of the migraine population 39. 
Because Migraine remains prevalent, disabling,undiagnosed and untreated in 
India,public health initiatives to improve diagnosis and treatment are needed.
Diagnosis
Migraine is a syndrome of recurrent headaches with a wide variety of 
neurological and non neurological manifestations. It is not simply a headache. 
Diagnosis of Migraine is not obtained solely by exclusion of other disorders. 
Positive diagnosis is possible. This should be based on information about the 
attack profile, on identification of probable triggers and on understanding of 
the  clinical  spectrum.  About  70%  of  Migraineurs  have  a  positive  family 
history.
14
IHC – 2 Classification of Migraine
IHC- 2 Code and Syndrome
1. Migraine
1.1 Migraine without aura
1.2 Migraine with aura
1.2.1 Typical aura with Migraine headache
1.2.2 Typical aura with Non migraine headache
1.2.3 Typical aura without headache
1.2.4 Familial  hemiplegic Migraine
1.2.5 Sporadic hemiplegic Migraine
1.2.6 Basilar type Migraine
1.3 Childhood periodic syndromes that are commonly precursors of 
migraine
1.3.1 Cyclical vomiting
1.3.2 Abdominal Migraine
1.3.3 Benign    paroxysmal vertigo of childhood
1.4 Retinal Migraine
1.5 Complications of migraine
1.5.1 Chronic Migraine
1.5.2 Status migrainosus
1.5.3 Persistent aura without infarction
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1.5.4 Migrainous  infarction
1.5.5 Migraine triggered seizure
1.6 Probable Migraine
1.6.1 Probable migraine without aura
1.6.2 Probable migraine with aura
1.6.3 Probable Chronic migraine
     
Migraine  can  be  divided  into  four  major  sub  types.  1.1  Migraine 
without aura is a clinical syndrome characterised  by headache with specific 
features  and  associated  symptoms.  1.2  Migraine  with  aura  is  primarily 
characterised  by  focal  neurological  symptoms  that  usually  precede  or 
sometimes  accompany  the  headaches.  Migraine  without  aura  is  the  most 
common subtype of migraine. It has a higher attack frequency and is usually 
more disabling than migraine with aura. Only less than 30% of attacks are 
migraine  with  aura.  Migraine  without  aura  is  the  disorder  most  prone  to 
become chronic and this chronic is aided by excessive use of immediate relief 
medications and  comorbidities.
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Migraine with aura
Definitions
The  syndrome  of  migraine  with  aura  (MA)  has  been  known  by  a 
variety  of  terms  over  the  years,  including  classic  or  classical  migraine, 
migraine accompanee, complicated migraine and depending on the nature of 
the  aura  symptoms,  ophthalmic,  hemiparesthetic,  hemiplegic,  or  aphasic 
migraine.
The  current  International  Headache  Classification  (IHC-2)   defines 
aura as follows:
A recurrent disorder manifesting in attacks of completely reversible 
focal neurological  symptoms with a mix of positive and negative features, 
which usually evolve over 5-20 minutes and lasts for less than 60 minutes, 
which may or may not be followed by headache.
This definition allows that the accompanying headache may be either 
of typical migraine type or another primary headache form, and also that aura 
may not necessarily be associated with headache at all [defined as "typical 
aura without headache" under IHC-2, and sometimes called acephalalgic or 
(erroneously) acephalgic migraine]. 
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Incidence
The incidence of neurological auras in the community is not known, 
but a recent study of 952 migraine patients attending a tertiary care center in 
Atlanta  found that just over one-third of migraineurs reported aura with about 
20% of all  migraine attacks  being associated with aura.  The average aura 
duration  was  about  27  minutes,  and  the  headache  phase  began  about  10 
minutes after the onset of aura. More than 90'% of auras were visual.
Migraine with aura may affect only 5 to 10% of the population, but 
auras  without  headache  are  much  more  common  and  frequently  go 
unrecognized or undiagnosed.
Knowledge of the characteristics of migraine headache and aura almost 
certainly influence the observed prevalence. For example, Alvarez recorded 
618  instances  of  migrainous  auras  preceding  headache  in  migraineurs. 
Overall, 12% of his male cases reported visual auras occurring in isolation, 
but among physicians (almost all male),   87% had experienced auras without 
headache . He concluded that aura without headache might be much more 
common than "classical" migraine.
Characteristics
Like epileptic auras, migraine auras usually begin with an excitatory 
phase  with  positive  symptomatology,  believed  to  reflect  the  advancing 
excitatory wave of spreading depression. For example, excitation of the visual 
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cortex results in auras such as "flashing lights," whereas auras arising in the 
primary sensory cortex cause paresthesia on the opposite side of the body, and 
so forth. The neuronal inhibition and, possibly the associated oligemia that 
follows, cause negative symptoms such as scotoma, dysphasia, numbness, and 
paresis. Such symptoms are not a feature of epileptic auras, although Todd's 
paresis might be analogous. This neural inhibition phase lasts much longer 
than  the  excitatory  phase,  and  indeed can  sometimes persist  for  weeks  or 
months-persistent aura without infarction and migraine coma.
Migraine  auras  occur  in  clear  consciousness  and  are  perceived  by 
patients as "real," although recognizing that they are not. They are generally 
considered to be hallucinations. A hallucination is the apparent perception of 
an external stimulus or object that is not actually present-perceiving things 
that  are  not  there-as  opposed to  an  illusion,  the  perception  of  an  external 
object  as  a  result  of  a  "false  belief'  or  misinterpretation  of  real  events  or 
inputs.Migraine  auras  can  also  produce  illusions,  such  as  vertigo  and 
metamorphopsias. The distinction is arguably an exercise in arcane semantics, 
but when interpreting visual symptoms, it  is  important to distinguish auras 
from  vivid  imagery,  i.e.,  images  that  appear  "in  the  mind's  eye."  Such 
perceptions are largely under voluntary Control.
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Classification of Auras
“Typical" auras- Visual            Simple
Positive, e.g., phosphenes and 
teichopsia 
Negative, e.g., scotoma and 
hemianopia
Complex e.g., visual 
metamorphopsia
Somesthetic Simple 
Positive, e.g., tingling
Negative, e.g., numbness
Complex Somesthetic 
metamorphopsia
Aphasic Expressive dysphasia
Receptive dysphasia
Dyslexia
"Atypical" auras
 Primary sensory    Olfactory 
Auditory
Visceral
Kinesthetic
Limb pain
Vestibulocochlear Vertigo
Deafness
Drop attacks
Motor Chorea
Dystonia
Hemiplegia
Higher integrative functions Memory
Mood
Perception and planning
"Typical" Auras 
Visual Auras
Visual auras originate in the visual cortex and are generated by cortical 
spreading depression (CSD)32. Such auras are typically simple, involving the 
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functions of the striate and extrastriate cortex. Complex auras, with symptoms 
suggesting involvement of visual and parietal cortical-association areas, are 
rare. It is characteristic of all visual auras that the images persist when the 
eyes are closed. The visual phenomena are often perceived as confined to one 
eye and described as such by the patient but are actually hemianopic. 
Positive symptoms: Simple auras usually include "positive" elemental 
phenomena, such as dazzling stars, sparks, or flashes, which are usually white 
but  sometimes  spectral,  occurring  singly  or  in  multiple  showers.  Patients 
usually describe them as "flashing lights." These primitive hallucinations are 
generally  referred to  as  scintillations  or  phosphenes.  Other  descriptions  of 
positive visual auras given by patients include "electric light bulb clement" 
and  "like  a  wriggling  snake."  As  noted  above,  the  more  formed  auras 
sometimes  have  colored  edges.  Less  commonly,  they  may  become 
progressively  more  pronounced  with  kaleidoscopic  effects.  A  common 
experience is of "shattering" of images into an irregular crystalline mosaic.
Visual Auras
Simple Elemental (scintillations, phosphenes, kaleidoscopic) 
Positive Blurring, heat haze, "water on glass" Teichopsia (scintillating
scotoma and fortification spectra)
Negative            Hemianopia/ Tunnel vision 
Blindness
Complex Visual metamorphopsia
Agnosia
Distortion of motion and space
Negative  symptoms: Negative  visual  aura  symptoms  are  actually 
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more common than positive symptoms and often occur in isolation. Typical 
impressions include "blurring" of vision, a rippling effect in the central fields 
like water running down glass, a "corona" around the image, or a heat haze. 
More dramatic negative symptoms include the classical expanding translucent 
scintillating scotoma. This may have a jagged edge, in which case the image 
is referred to as teichopsia or fortification spectrum, as first clearly illustrated 
by Hubert Airy.The fortification spectrum, so called by Dr. John Fothergill 
(1712-1780) because of its similarity to the castellations of a battlement, such 
as surrounds the French town of Lille  or the Dutch town of Naarden, starts as 
a  zigzag  figure  near  the  fixation point  and gradually  spreads  right  or  left 
(depending  on  which  visual  cortex  is  generating  the  image),  assuming  a 
laterally  convex shape with an angulated scintillating edge (the  expanding 
angular spectrum of Gowers), leaving variable degrees of absolute or relative 
scotoma in its wake. The zigzag edge, the positive part of the aura, may be 
colored. 
Migraine specks, geometrical forms and shimmering in the visual field 
are Scotoma without positive phenomenon and is usually enlarges gradually. 
More complicated visual auras include teichopsia, or fortification spectra (the 
characteristic aura of migraine) metamorphopsia, micropsia, macropsia, zoom 
vision and mosaic vision. The fortification spectrum that is zig zag figure near 
the  point  of  fixation  that  may  gradually  spread  right  or  left  and  assume 
laterally convex shape with an angulated scintillating edge leaving variable 
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degree absolute or relative scotoma in its wake.
 Next in frequency are sensory distribuances in the form of pins and 
needles moving slowly from the point  of origin and affecting a greater or 
smaller part of the side of body and face. Parathesias are often cheiro aural. 
Numbness starts in hand, migrates up the arm and jumps to involve the face, 
lips  and  tongue.  Weakness  is  rare,  occurs  in  association  with  sensory 
symptoms. Weakness is unilateral and it may be classified as either familial 
hemiplegic  migraine  (1.2.4)  or  sporadic  hemiplegic  migraine  (1.2.5)  .Less 
frequent  are  speech  disturbances,  usually  dysphasic  but  often  hard  to 
characterise.  Apraxia,  aphasia,  agnosia,states  of  altered  consciousness 
associated  with  deja  vu  or  jamais  vu  and  elaborate  dreamy,  nightmarish, 
trancelike or delirious states can occur.
The  Migraine  aura  was  believed  to  be  caused  by  cerebral 
vasoconstriction and the headache by reactive vasodilatations. This explained 
the throbbing quality and its relief by ergots. It is now believed that aura is 
caused by neuronal dysfunction. Headache often begins while cortical blood 
flow  is  reduced  32.  This  headache  is  not  caused  by  simple  reflex 
vasodilatation.
The migrainous fortification spectrum corresponds to an event moving 
across the cortex at 2 - 3 mm / min. Noxious stimulation of the rodent cerebral 
cortex produced a spreading decrease in electrical activity that moved at 2 – 3 
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mm / min. Cortical spreading depression (CSD) is characterised by shifts in 
cortical steady state potential;  transient increases in potassium, nitric oxide 
and glutamate levels and transient increases in cerebral blood flow followed 
by sustained decrease in cerebral blood flow (CBF). Olesen and colleagues 32 
found 17% - 35% reductions in posterior cerebral blood flow which spread 
anteriorly at 2 – 3 mm / min. Reduced cerebral blood flow persisted from 
30minutes to 6 hrs and then cerebral blood flow slowly return to baseline or 
even increased. The rates of progression of spreading oligemia are similar to 
those  of  migrainous  scotoma  and  cortical  spreading  depression  which 
suggests that they are related32. Additional studies support the hypothesis that 
cortical spreading depression produces the aura. During visual auras, cerebral 
blood flow decreased 15 % - 53 %, cerebral blood volume decreased 6% - 
33%  and  mean  transit  time  increased  10% -  54% in  the  occipital  cortex 
contralateral to where the aura was experienced. The perfusion defect moved 
anteriorly.  There  would  appear  to  be  preferential  pathways  for  the 
propagation of CSD, because certain auras, defined under IHC-2 as “typical” 
(visual  hallucinations,  somasthetic  and  dysphasic  symptoms)  are  more 
common than other forms of aura. Motor auras, for example, are distinctly 
uncommon.  It  seems  likely  that  CSD  is  normally  triggered  by  a  critical 
increase  in  interstitial  K+ concentration.  The  control  of  interstitial  K+ 
concentration  depends  on  glia.  Neurons  are  a  source  of  K+,  while  glia 
represent a K+   “sink”, so it  would therefore be expected that CSD would 
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occur  more  readily  in  cortical  sites  with  a  low  glia-to-neuron  ratio.  The 
susceptibility of brain areas to CSD probably depends on local glia-dependent 
K+ homeostasis, and that the occipital cortex might be a “hot spot” for CSD 
because of its relatively low gila-to-neuron ratio compared, for example, to 
the  frontal  cortex  .  It  is  also  clear  that  CSD is  more  readily  observed in 
lissencephalic than gyrencephalic animals such as primates, which have larger 
cortical glia-to-neuron ratios; and it cannot be elicited at all in the spinal cord, 
which has comparatively few nerve cell bodies . Visual stimulation was used 
to trigger the headache in migraineurs. A wave of increased BOLD (Blood 
oxygen level dependent) functional magnetic resonance imaging signal and 
then decreased BOLD signal propagated into contiguous occipital cortex at 3 
– 6 mm / min. 
Association of interatrial shunts and migraine headaches
             The foramen ovale is composed of the septum primum (left atrial 
side,  fenestrated  cranially)  and  the  septum  secundum  (right  atrial  side, 
fenestrated caudally) joined in parallel forming a slit-like valve that shunts 
oxygenated  blood to  the  systemic  circulation  during  fetal  development.  A 
patent foramen ovale (PFO) results from lack of normal closure postnatally. 
Atrial septal defects (ASD) and  patent foramen ovale (PFO) are present in 
approximately  25%  of  patients  at  autopsy17 and  45%  of  patients  with 
cryptogenic stroke 2,23,42. An underlying mechanism of stroke in such patients 
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includes transient right-to-left shunt during the release phase of Valsalva with 
passage of venous micro emboli systemically (i.e., paradoxic embolism). It is 
estimated  that  70,000  strokes  are  associated  with   patent  foramen  ovale 
annually in the U.S.
       Neurological decompression illness is more frequent in divers with right 
to  left  shunt  than those  without.This  right  to  left  shunt  allows bubbles  to 
bypass the filter  and bubbles may then embolise neurological tissues 51,53.      
             
          Diagramatic representation of opening of PFO during valsalva release
           Del sette and colleagues showed that right to left cardiac shunt where 
present  in  41% patients  with  migraine  with  aura  compared  with  16  % of 
controls9. Anzola of and colleagues obtained similar results 20,16 which showed 
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that right to left shunts were present in 48% of individuals with migraine with 
aura compared with 20%  in controls. Dalla Volta and colleagues showed that 
patent foramen ovale was present in 61.9% of patients with migraine with 
aura and 16.2% of patients with migraine without aura7. These observations 
suggest  that  an atrial  shunt  merely  fascilitates  migraine  with aura.  It  may 
cause aura by micro embolisation or vasoactive chemicals which bypassed the 
lungs.        
           Peter  Wilmshurst  and Simon Nightingale postulated  a venous agent 
possibly   5  Hydroxy  tryptamine  bypass  the  lung  filter  through  persistent 
foramen ovale and that generates attacks migraine52.    Peter  Wilmshurst  and 
Simon Nightingale concluded that individuals with a history of migraine with 
aura should be screened for the presence of  right to left shunt before they 
dive or be exposed to subatmospheric decompression51.
Azarbal et al.  retrospectively evaluated changes in migraine patterns 
in  89  patients  with  cryptogenic  stroke  following  ASD/PFO  closure  and 
showed a 42% migraine prevalence, with 62% having migraine with aura5. At 
one-year  follow-up,  there  was  complete  resolution  of  migraine,  starting 
immediately postprocedure, in 60% of patients (75% in those with aura), and 
improvement  in  the  remaining  40%.  Reisman et  al.  in  a  study  of  similar 
methodology,  treated 162 patients  with presumed paradoxic  embolism and 
showed a 35% prevalence of migraine, with 68% having migraine with aura29. 
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Complete  resolution  of  migraine  was  noted  in  56%  and  significant 
improvement in 14%. These two studies corroborate several  recent studies 
showing similar results, with enhanced improvement in patients with migraine 
with aura 15,16,22,30,37,55.
Effect of PFO Closure Devices on Migraine Headache
Authors (Ref.)     # of         # (%) With              Mean     Resolution 
Improved
Subjects   Migraine           Follow-Up   %                   %
      
Wilmshurst et aI. (53) 37 21 (57)       17 months      48               38
Morandi et al. (11) 17 17 (100)     12 months     29                59
Post et aI. (30) 66 26 (39)        6 months      84      N/A
Schwerzmann et aI. (37) 215 47 (22)       24 months     N/A             83
Azarbal et al. (1) 89 37 (42)        6 months      60                16
Reisman et al. (29) 162 57 (35)       12 months     56      14
Total 586 205 (35)                    55                42
N/ A = not applicable; PFO = patent foramen ovale.  
Phases of migraine
Four  different  phases  of  migraine  recognised  are  prodrome,  aura, 
headache(during which associated symptoms are experienced) and recovery 
or resolution phase.
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1. Prodrome
The prodromal symptoms may be present in some patients during some 
attacks but it is not universally present. It may be difficult to identify but with 
patients are specifically asked about the premonitory symptoms in the 24 hr 
period before the headache, they often describe symptoms such as irritability, 
excitability, hyperactive or depression and helpful in diagnosis. Premonitory 
symptoms may also include hypoactivity, craving for certain particular foods, 
repetitive yawning, neck tightness and so on.
2. Aura
The  diagnosis  is  usually  evident  by  careful  history  alone,  although 
there  are  secondary  mimics  including  carotid  dissection,  seizure  and 
arteriovenous malformations. 
Visual  aura  is  the  most  common  type  presenting  as  fortification 
spectrum or scotoma. Next in frequency are sensory disturbances in the form 
of pins and needles(positive features) and / or numbness (negative features). 
Less frequent are speech disturbances – dysphasia.    
Symptoms  usually  follow  one  another  in  succession  begining  with 
visual than sensory symptoms and dysphasia but reverses and other orders 
have been noted. After an initial consultation, use of an aura diary may help in 
29
diagnosis.
If  the  aura  begins  after  the  age  of  40,  when  negative  features  are 
predominant  (hemianopia)  or  when  aura  is  prolonged  or  very  short,other 
causes should be ruled out espescially transient ischemic attacks.
3. Headache phase
About 60%  of  headaches in migraines are predominantly unilateral. It 
is important to note that headache occur alternating side. It can start on one 
side and go to other side during the same attack or it may be different sides in 
different attacks.  Approximately 40 – 45 % of patients may have bilateral 
headaches. A pulsating headache is very characteristic of migraine but not 
always diagnostic.
Migraine headache is  of moderate to  severe intensity  unlike tension 
type  headache  which  is  usually  mild.  Migraine  headaches  interfere  with 
patients ability to function whereas the majority of tension type headaches do 
not.
Migraine  headache  is  aggravated  by  any  activity  or  posture  that 
increases intracranial pressure such as coughing, sneezing, bending down or 
climbing  stairs  or  physical  exercises.  Therefore  typically  patients  with 
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migraine generally do not like to move and prefer to lie down without much 
movement of the head or body. The location of the headache does not help in 
the  diagnosis.  Headache  even  though  typically  in  the  temples,  could  be 
frontal, occipital or suboccipital. It may be unilateral or bilateral. Associated 
symptoms  are  also  important.  Anorexia,  nausea  and  /  or  vomiting  often 
accompany migraine headache and are very helpful diagnostic features. Any 
condition with increased intracranial pressure or meningeal irritation cause 
nausea  and   vomiting  but  major  difference  between  such  disorders  and 
migraine is that migraine is recurrent.
There  is  visually  heightened  sensory  perception  manifested  by 
photophobia, phonophobia and dislikes for smells. Patients seek a dark quiet 
room. Behaviour of the patient during attacks may be altered. They may be 
irritable  and  their  memory  &  concentration  may  be  impaired.  When 
behavioural symptoms occur they may be    misdiagnosed as a psychological 
condition.  Depression,  fatigue,  anxiety,  nervousness,  irritability  and 
impairment of concentration are common.
Recent  research  has  clearly  indicated  that  significant  percentage  of 
patients  with  migraine  would  develop cutaneous allodynia  of  the  scalp  or 
extracephalic areas of the body such as limbs. Non painful stimuli becomes 
uncomfortable  or  painful.  It  is  the  result  of  central  sensitisation  of  the 
trigeminal pathways.  The allodynic brushing /  coombing the hair,  wearing 
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ponytails,  and  rubber  bands,  and  difficulty  lying  on  the  side  of  headache 
beacuse of soreness and tenderness of the scalp. The allodynic symptoms in 
the  extracephalic  areas  include  tingling  and  increased  sensitivity  as 
manifested by difficulty wearing neck chains and discomfort on having the 
blanket touch the body. 
The practical  importance of recognizing allodynia has recently been 
pointed out by Berstein et al. . Central sensitization and resultant allodynia 
begins its process in the first hour of migraine attack and becomes established 
by 4 hours.The best chance of making a patient pain free with triptan is giving 
the drug before the allodynic process becomes established . Therefore, early 
treatment with triptan before allodynia develops is extremely important. 
Identification of  provocational  trigger  for  a  headache is  evidence in 
support  of  the  classification  of  headache  as  benign.  It  is  unusual  for  an 
organic disorder to show sensitivity to triggers.
Common provocational triggers for migraine
Hormonal triggers         Menstruation, ovulation, oral contraceptive, 
                                               Hormonal replacement
Dietary triggers        Alcohol,  nitrite-laden  meat,  monosodium 
glutamate, 
                                         aspartame, chocolate, aged cheese, missing a meal.
Psychological triggers     Stress, period after stress (weekend or vacation), 
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                                         anxiety, worry, depression
physical / environmental Glare,flashing lights, visual stimulation, fluorescent 
lighting, odors, weather changes, high altitude
sleep-related triggers Lack of sleep, excessive sleep
Miscellaneous triggers  Head trauma, physical exertion, fatigue, 
 Drugs                     Nitroglycerin,   histamine,  reserpine, 
hydralazine,ranitidine,                                                          
                                    Estrogen.
Resolution phase
After the headache, the patient often feels tired, washed out, irritable, 
or restless and can have impaired concentration, scalp tenderness, or mood 
changes.  Some feel  unusually refreshed or euphoric after an attack; others 
experience depression and malaise.
Migraine Variants
Various  migraine  variants  are  recognized  and  classified  in  the  IHS 
classification.
Familial Hemiplegic Migraine (FHM)
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FHM characterized by familial occurrence of hemiparesis associated 
with  migraine  like  headaches.  The  aura  consists  of  fully  reversible  motor 
weakness and at least one of the following : 
(a)  fully  reversible  visual  symptoms  (including  flickering  lights,  spots,  or 
lines) or negative features (i.e., loss of vision);
(b) fully reversible sensory symptoms including positive symptoms (i.e., pins 
and needles) or negative features (i.e., numbness); and
(c) fully reversible dysphasic speech disturbances. Usually the auras develop 
gradually over 5 minutes and different auras occur in succession over a period 
of 5 minutes or more each aura symptom usually lasts >5 minutes, but <24 
hours.  The  most  important  diagnostic  feature  is  that  at  least  one  first  or 
second-degree  relative  has  had  attacks  of  similar  kind.  So  the  familial 
occurrence of such attacks with hemiparesis is diagnostic. It may be difficult 
to distinguish weakness from sensory loss.
Now genetic data have allowed a more precise definition of FHM than 
previously. Specific genetic  subtypes of familial  hemiplegic migraine have 
been identified. 
In FHM 1, there are mutations in CACNA1A gene on chromosome 19 
and in FHM2, mutations occur in ATP1A2 gene on chromosome 1q21-23 . 
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It has been shown that FHM 1 very often has basilar type symptoms in 
addition to the typical aura symptoms and that headache is virtually always 
present.  During  FHM1  attacks  disturbances  of  consciousness  (sometimes 
including coma, fever, Cerebrospinal fluid  pleocytosis, and confusion) can 
occur.  FHM1  attacks  can  be  triggered  by  (mild)  head  trauma.  In 
approximately 50% of FHM1 families, chronic progressive cerebellar ataxia 
occurs independently of the migraine attacks. FHM is very often mistaken for 
epilepsy and unsuccessfully treated as such.  
Sporadic Hemiplegic Migraine 
In sporadic hemiplegic migraine, attacks occur with a migraine aura 
including motor weakness usually on one side without a  family history of 
similar illness in first - or second degree relatives. The main manifestation is 
fully reversible motor weakness, sometimes associated with visual or sensory 
or  dysphasic  aura.  Studies  have  shown  that  sporadic  cases  occur  with 
approximately the same prevalence as familial cases. Attacks have the same 
clinical characteristics as those of familial hemiplegic migraine.
Sporadic cases always require neuroimaging and other tests to rule out 
other causes. Lumbar puncture is also necessary to rule out pseudomigraine 
with temporary neurological symptoms and lymphocytic neutrocytosis in the 
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Cerebrospinal  fluid.This  condition  is  more  prevalent  in  males  and  often 
associated with transient hemiparesis and aphasia.   
Basilar- Type Migraine 
In basilar-type migraine, the migraine aura symptoms clearly originate 
from the brain stem and/or from both hemispheres simultaneously, but there is 
no motor weakness. The aura in basilar - type migraine consists of at least two 
of  the  following  fully  reversible  symptoms,  but  no  motor  weakness  a) 
dysarthria,  (b) vertigo, (c) tinnitus,  (d) hyperacusia,  (e) diplopia,  (f)  visual 
symptoms simultaneously in both temporal and nasal fields of both eyes, (g) 
ataxia, (h) decreased level of consciousness, and (i) simultaneously bilateral 
paresthesias. All the auras developed gradually over 5 minutes or more, and 
different aura symptoms may occur in succession over more than 5 minutes. 
Each aura symptom lasts usually 5 minutes or more and usually less than 60 
minutes. The headaches following these are similar to those seen in patients 
with migraine without aura. In all these types of migraine, any other cause 
that  could  produce  similar  symptoms  have  to  be  ruled  out.  Basilar-type 
attacks are mostly seen in young adults. Many patients who have basilar type 
attacks also report attacks with typical aura. Differential diagnosis of basilar-
type of migraine is anxiety and panic attacks, which may cause some of the 
symptoms  just  described.  The  associated  severe  headache  and  the 
development pattern of the aura symptoms differentiates basilar-type attacks 
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from a panic attack causing similar symptoms.
Childhood Periodic Syndromes: Migraine Precursors
Cyclical Vomiting 
Cyclical vomiting occurs in recurrent episodes, usually stereo typed in 
individual patients, of vomiting and intense nausea. The attacks are associated 
with pallor and lethargy. There is complete resolution of symptoms between 
attacks.  The  clinical   features  of  this  syndrome  resemble  those  found  in 
association with migraine headaches. 
Multiple threads of research over the last  years  have suggested that 
cyclical  vomiting  is  a  condition  related  to  migraine  and  may  run  as  a 
precursor of migraine in children.
Abdominal Migraine 
This is  an idiopathic recurrent disorder seen mainly in childern and 
characterized  by  episodic  midline  abdominal  pain  manifesting  in  attacks 
lasting 1 to 72 hours with normality between episodes. Pain is moderate to 
severe in intensity and associated with vasomotor symptoms of nausea and 
vomiting. The abdominal pain has the following characteristics: (a) mid-line 
location, periumbilical or poorly localized, (b) dull or just sore quality, and (c) 
moderate or severe intensity. During the abdominal pain, at least two of the 
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following symptoms may be present: (a) anorexia, (b) nausea, (c) vomiting, 
and (d) pallor. All other organic conditions have to be ruled out in order to 
make  a  positive  diagnosis.  Pain  may  be  severe  enough  to  interfere  with 
normal daily activities. Children may find it difficult to distinguish anorexia 
from nausea. The pallor is often accompanied by dark shadows under the eye. 
In  a  few patients,  flushing  is  a  predominant  vasomotor  phenomena.  Most 
children with abdominal migraine develop migraine headache later in life.
Benign Paroxysmal Vertigo of Childhood 
The probably heterogeneous disorder of benign paroxysmal vertigo of 
childhood  is  characterized  by  recurrent  brief  episodic  attacks  of  vertigo 
occurring without warning and resolving spontaneously in otherwise healthy 
children. Neurological examination and audiometric and vestibular function 
tests are normal. The attacks are usually short lived. It may be associated with 
nystagmus or  vomiting.  Unilateral  throbbing headache may occur  in  some 
patients.
Retinal Migraine 
Retinal  migraine  manifests  as  repeated  attacks  of  monocular  visual 
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disturbances including  scintillations, scotoma, or blindness, associated with 
migraine headache. These are fully reversible episodes and always confined 
to the monocular visual field. Headache would meet the criteria for migraine 
without aura. The ophthalmological examination is usually normal between 
attacks. Other causes of transient monocular blindness have to be ruled out. 
One of the confusing issues is that  some of the patients who complain of 
monocular  visual  disturbances  may  infact  have  hemianopia.  Some  cases 
without  headache have been reported,  but  in  these  cases,  their  migrainous 
nature cannot be ascertained. Other causes of transient monocular blindness 
(amaurosis fugax),  such as optic neuropathy or carotid dissection, must be 
excluded.
COMPLICATIONS OF MIGRAINE 
Chronic Migraine
Chronic migraine is defined as migraine occurring for 15 or more days 
per month for more than 3 months in the absence of medication overuse 
Status migrainosus
Status migrainosus are debilitating migraine attacks lasting more than 
72 hours. Usually these occur in patients with migraine without aura who may 
have  unremitting  headache  for  more  than  72  hours.  They  are  of  severe 
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intensity. These are the type of patients who end up in the emergency room 
for  treatment.  Note  that  status  migrainosus  can  be  caused  by  medication 
overuse and that factor has to be evaluated. The patients who are in status 
migrainosus  usually  are  very  sick  with  extreme nausea  and vomiting  and 
often dehydrated. Rehydration is an essential part of the treatment.
Persistent Migraine Aura without Infarction 
These are patients with aura symptoms persisting for more than 1 week 
without any radiographical evidence of cerebral infarction. This aura could be 
visual, sensory, or motor. The visual aura is often bilateral and may last for 
months or years. It is important to exclude organic conditions like posterior 
leukoencephalopathy in persistent cases.
Migrainous Infarction 
An occasional patient with migraine with aura may develop cerebral 
infarction  with  some  persistent  neurological  symptoms.  Their  attacks  are 
typical of previous attacks of migraine with aura, but the difference is that the 
aura symptoms persist  for  more than 60 minutes and neuroimaging would 
demonstrate an ischemic infarction in the relevant areas. Ischemic stroke in 
migraineurs can only be made if the infarction occurs during a typical attack 
of migraine with aura. Increased risk for stroke in migraine patients has been 
demonstrated in  women under  the age 45 in several  studies.  Evidence for 
40
association  between  migraine  and  stroke  in  older  women  and  in  men  is 
inconsistent.  Younger  women  with  migraine  with  aura,  who  are  heavy 
smokers and who are on birth control pills, may increase their risk for cerebral 
infarction. The usual area of cerebral infarction is the posterior occipital lobe 
and  is  typically  a  wedge-shaped  infarction.  In  patients  with  migrainous 
infarction, other predisposing causes for cerebral infarctions, such as cardiac 
abnormalities, anticardiolipin antibody syndrome, and collagen disease, have 
to be ruled out.
Migraine- Triggered Seizure 
A  seizure  triggered  by  a  migraine  aura  can  occasionally  occur. 
Migraine  and  epilepsy  are  paroxysmal  brain  disorders.  Migraine  like 
headaches  are  quite  frequently  seen in  the  postictal  period  of  an epileptic 
attack, and sometimes a seizure occurs during or following a migraine attack. 
This phenomenon, some times referred to as migralepsy, has been described 
in patients with migraine with aura. This is a rare condition.
Probable Migraine 
A previously used term was migrainous disorder . These are attacks 
missing one of the features needed  to fulfill  all the criteria for a disorder 
described  in  the  criteria  for  migraine  with  aura  and  without  aura.  The 
prevalence of probable migraine is quite high in the clinical population. They 
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sould be considered as migraine for all practical purposes and treated as such.
Menstrual Migraine 
The International Headache Society recognizes two forms of menstrual 
migraine (1) pure menstrual migraine without aura and (2)menstrually related 
migraine without aura. 
Pure Menstrual Migraine without Aura
These  are  migraine  attacks  in  a  menstruating  woman,  fulfilling  the 
criteria for migraine without aura. The attacks should occur exclusively on 
day 1, plus or minus two, that is, days -2 to +3 of menstruation in at least two 
out of three menstrual cycles and no other times of the cycle. The first day of 
menstruation is counted and the preceding day as -1. There is no day zero. For 
the  purposes  of  classification,  menstruation  is  considered  endometrial 
bleeding resulting from either normal menstrual cycle or from withdrawal of 
exogenous progesterones as in the case of combined oral contraceptives and 
cyclical hormone replacement therapy.
Menstrually Related Migraine without Aura 
In this entity, attacks in a menstruating woman should occur on day 1 
plus or minus two, that is, days minus to plus three of  the menstruation in at 
least two out of three menstrual cycles and additionally at other times of the 
42
cycle.  In  other  words,  these  patients  have migraines  around the  menstrual 
time plus other migraines at  other times of the month.  The importance of 
distinguishing  between  pure  menstrual  migraine  and  menstrually  related 
migraine without aura is that the hormone prophylaxis is more likely to be 
effective for pure menstrual migraine. In order to make a certain diagnosis, a 
respectively documented evidence by a proper diary is necessary. 
Menstrual  migraines  are  mostly  migraine  without  aura  in  a  woman 
who has migraine both with aura and without aura Migraine aura does not 
appear to be associated with menstruation. Menstrual migraines are usually 
prolonged, can occur for 4 or 5 days, as long as the menstruation lasts. It is 
more difficult to treat. Recurrence of headache even with triptans can occur.
Transesophageal contrast echocardiography:
           Transesophageal contrast echocardiography is the most sensitive 
diagnostic test available for detecting a persistent foramen ovale followed by 
transcranial  doppler  and  transthoracic  cardiography(33,9,18).Intravenous 
saline contrast was given during  transesophageal contrast echocardiography. 
Persistent foramen ovale is judged to be present if any microbubbles seen in 
left  side  chambers  within  3  cardiac  cycles  from  the  maximal  right  atrial 
opacification after injection of agitated saline. Agitated saline is prepared by 
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mixing  0.5 -1 ml of air with 10ml of normal saline through the 2 syringes in 
the  peripheral  intravenous  line.Injection  is  performed  with  and  without 
valsalva maneuver.Cough during injection increase the sensitivity of detecting 
persistent foramen ovale over that achieved by valsalva maneuver
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MATERIALS AND METHODS
In  a  cross  sectional  case  control  study,  transesophageal  contrast 
echocardiography was done in 42 migraine patients. Among them 21 patients 
were migraine with aura and 21 patients  were migraine without  aura.  We 
perform  transesophageal  contrast  echocardiography  and  assessed  anatomy 
and size of the shunt lesions. Cardiologist   was blinded for migraine history. 
All the patients were the out patients of the Neurology department.
SITE OF STUDY 
Dept  of  Neurology,  Govt.  Stanley  Medical  College  &  Dept.  of 
Cardiology, Govt. Stanley Medical College
PERIOD OF STUDY : JANUARY 2006 –MARCH  2008
INCLUSION CRITERIA
l. Age > 12 Years 
2. Patients who satisfied the criteria of the International Headache 
Society    for Migraine. 
3. Patients who are willing to participate in the study  & given the 
written consent. 
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EXCLUSION CRITERIA
l. Age <12 Years 
2. Patients  who not satisfied the criteria  of   the  International 
Headache Society for Migraine.
3. Patients who are not willing to participate in the study & not 
given the   written consent. 
TOOLS USED: 
1. THE CRITERIA OF THE INTERNATIONAL HEADACHE SOCIETY 
FOR MIGRAINE.
1.1 Migraine without aura 
Diagnostic criteria: 
A . At least 5 attacks  fulfilling B - D. Migraine days Frequency < 15 days/
month
B. Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated).
C. Headache has at least two of the following characteristics: 
1. Unilateral location
2. Pulsating quality 
3. Moderate or severe pain intensity 
4. Aggravation  by  or  causing  avoidance   of  routine  physical 
activity  (e.g., walking or climbing stairs) 
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D. During headache at least one of the following: 
1. Nausea and/or vomiting 
2.  Photophobia and phonophobias.
E. Not attributed to another disorder 
1. 3.1 Typical aura with migraine headache 
Description:  Typical aura consisting of visual and/or sensory and/or speech 
symptoms.  Gradual  development,  duration  no  longer  than  one  hour  and 
complete  reversibility  characterize  the  aura  which  is  associated  with  a 
headache fulfilling criteria for migraine without aura (1.1 ) 
Diagnostic criteria: 
A. At least two attacks fulfilling criteria B . E 
B. Fully reversible visual and/or sensory and/or speech symptoms but 
no motor weakness 
C. At least two of the following: 
1. Binocular  unilateral  Homonymous  visual  symptoms  and/or 
unilateral  sensory  symptoms     including  excitation  positive 
features  (flickering  light,  pins  and needles)  and/or  depression 
negative features (blindness,scotoma or numbness) 
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2. At least one symptom develops gradually over  5  minutes 
and/or different symptoms occur in succession. 
3. Each symptom lasts >5 minutes and <60 minutes 
D. Headache  that  meets  criteria  B  -D for  migraine  without  aura  (1.1) 
begins during the aura or follows aura within 60 minutes 
D. Not attributed to another disorder. 
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2. MIDAS SCORE
l. How many days in past 3 months -missed work or school because of 
your  headache?
2. How  many  days  in  past  3  months-productivity  at  work  or  school 
reduced by  half or   more because of your headache?
3. How many days in past 3 months-not do household work because of 
your  headache? 
4. How  many  days  in  past  3  months-productivity  at  household  work 
reduced by half or  more because of your headache?
5. How many days in past 3 months-did you miss family ,social or non 
work  activities  because of your headache?
A. On how many days in the past 3 months did you have a headache?
B. On a scale of 0-10, how painful were these headache on average? 
Total  MIDAS  Score: MIDAS  Grade-  (Grade1minimal  -score  0-5,mild 
II-6-10, moderate III-11-20, severe IV-21+- Sum of lost days due to headache 
for questions 1-5) 
49
3. TRANSESOPHAGEAL CONTRAST ECHOCARDIOGRAPHY
Transesophageal  contrast  echocardiography  was  performed  after 
obtaining  informed  consent  by  using  multiplane  transesophageal 
echocardiography  5MHZ  transducer  interfaced  with  Aloka4000  SSD. 
Transesophageal contrast echocardiography was performed blind to migraine 
history.Bubble  contrast  was  produced  by  pushing  about  10  ml  Normal 
saline  ,0.5  ml  venous  blood  and  0.5  ml  air  back  and  forth  between  two 
syringes   connected  by  a  three  way  tap  until  there  were  no  visible 
bubbles.This mixture was injected through a 21 gauge butterfly needle into a 
left  anticubital  vein.With  valsalva  manouever  transesophageal  contrast 
echocardiography was performed.Shunt is graded according to the number of 
bubbles.
               Small shunts-fewer than 6 bubbles
               Medium shunts-6-20  bubbles
               Large shunts->20  bubbles
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OBSERVATION AND RESULTS
Total no of patients : 42
                      Male  : 11
                   Female  : 31 
Female to Male ratio : 2.8:1
No of Migraine patients with aura : 21
                                             Male : 6
                                          Female : 15 
                    Female to Male ratio : 2.5:1
No of Migraine patients without aura : 21
                                                   Male : 5
                                              Female : 16 
                         Female to Male ratio : 3.2:1
Age
             Range                        : 16-55 (years)
             Mean  ±SD          : 27.35±9.88 (years)
                 Male                : 29.90±12.10(years)
                 Female            : 25.5±9.10(years)
             t=0.94    p=0.35 NS
Duration of Headache
             Range                        : 2-10 (years)
             Median                      : 3(years)
No of Patients with family history : 10(25%)
                Migraine with aura      : 6(29%)
                Migraine without aura : 4(19%)
No of patients with unilateral headache : 25(60%)
      Migraine patients with aura : 12(57%)
      Migraine patients without aura : 13(62%)
No of patients with autonomic signs : 40 (100%)
No of patients with severe MIDAS SCORE: 18(43%)
   Migraine patients with aura : 16(76%)
   Migraine patients without aura : 2(10%)
Average MIDAS Score
     Migraine patients with aura : 22.55±4.44
     Migraine patients without aura : 14.95±4.89
      P value=0.001 significant
   Average MIDAS Score : 18.75±6.01
No of  patients  with CT Scan abnormalities: Nil
No of  patients  with ANA,CRP,RA Factor positivity: Nil
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AGE  &SEX DISTRIBUTION
Age 
group(years)
Migraine with aura Migraine without aura
Male Female Total Male Female Total
Total
No .of
patients
15-24 2 8 10 2 6 8 18
25-34 2 5 7 1 9 10 17
35-44 1 - 1 2 1 3 4
45-54 1 1 2 - - - 2
>55 - 1 1 - - - 1
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MIGRAINE TYPES
Type Male Female Total
Migraine with aura 6 15 21
Migraine without aura 5 16 21
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FAMILY HISTORY
Family 
history
Migraine with aura Migraine without aura
Male Female Total Male Female Total
Total
No .of
patients
Positive 1 5 6 - 4 4 10
Negative 5 10 15 5 12 17 32
MIDAS SCORE SEVERITY
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MIDAS 
Score
Migraine with aura Migraine without aura
Male Female Total Male Female Total
Total
No .of
patients
Minimal - - - - - - -
Mild - - - - 5 5 5
Moderate - 5 5 9 5 14 19
Severe 6 10 16 1 1 2 18
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TEE FINDINGS IN MIGRAINE PATIENTS
Sl.No
TEE
Findings
Migraine with aura Migraine without aura
Male Female Total Male Female Total
1. Normal 3 11 14 5 15 20
2. PFO 1 1 2 - - -
3. ASD(0S) 2 3 5 - - -
4. ASD(SVC) - - - - 1 1
Total 6 15 21 5 16 21
Χ2=7.78  p=0.05 SIGNIFICANT
SHUNT LESIONS IN MIGRAINE PATIENTS
Migraine type PFO ASD(OS) ASD(SVC) Total
Migraine with aura 2 (10%) 5(24%) - 6(34%)
Migraine without aura - - 1(5%) 1(5%)
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Correlation of  shunt  and migraine severity
Migraine Group
Midas Score  Severity
Mild Moderate Severe
Migraine with shunt 5 18 11
Migraine without Shunt - 1 7
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Correlation of  shunt lesions with severity
TEE Finding
MIDAS SCORE GRADING
Mild Moderate Severe
Normal 5 18 11
ASD(OS) - - 5
PFO - - 2
ASD(SVC) - 1 -
DISCUSSION
Out of 42 patients ,21 patients met the diagnostic  criteria for migraine 
with aura and 21 patients met the the diagnostic criteria for migraine without 
aura. The female to male ratio is 2.8:1.
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Age distribution:
The age group  ranged from 16 years to 55 years.For the purpose of 
analysis the study group was divided into five categories.
1.15-24 years     2.25-34 years    3.35-44 years   
4.45-54 years     5.>55 years
The  maximum  distribution  of  patients  were  between  15-34 
years(33/42).Only  three  cases  belonged  to  age group above 35 years.The 
female preponderance more in younger age group 15-34 years(28/34).
Family history
Family history was present in  25% of patients. 29% of migraine with 
aura  patients   had  family  history.But  only  20% of  migraine  without  aura 
patients had family history.
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MIDAS Score
MIDAS Score was severe in 76% of  migraine with aura patients. But 
only in 10% of migraine without aura patients,MIDAS Score was severe.
Average MIDAS Score in migraine with aura patients was22.55±4.44. 
In migraine without aura patients, average MIDAS score was 14.95±4.89. P 
value was 0.001 which is significant.
In all  patients,  ANA,CRP and RA Factor were negative and CT scan 
was normal.
Transesophageal contrast echocardiography findings
Shunt  lesion  was  present  in  34%  of  migraine  with  aura 
patients.Osteum secundum type of atrial septal defect  was present in  24% of 
migraine  with  aura  patients.Patent  foramen  ovale  was  present  in  10%  of 
migraine with aura patients.Only 5% of migraine without aura patients had 
atrial  septal  defect  of  sinus  venosus  type.  P  value  is  0.05  which  is 
significant.So,  transesophageal  contrast  echocardiography  is  of  immense 
value in the workup of  migraine with aura patients.Since the shunt lesion was 
present in 34% of patients,closure of the shunt may result in remission of 
migraine symptoms.
Del  sette and colleagues showed that right to left shunts were present 
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in 41% of  migraine with aura patients compared with 16% of controls9.In our 
study  shunt  lesion  was  found  in  34%of   migraine  with  aura  patients.The 
increased prevalence of  right  to  left  shunts  in  migraine  with aura  patients 
suggests a causal relationship.
Magalhaes E et  al  concluded migraine with aura  occurred more in 
atrial septal defect  cases and atrial septal defect increase the frequency of 
migraine crises2.In our study Osteum secundum type of atrial septal defect 
was present in  24% of  migraine with aura patients.,In individuals with a 
right to left shunt, a lower dose of venous trigger substances may be needed to 
induce  migraine  because  the  shunt  permits  the  pulmonary  filter  to  be 
bypassed.5,45,49.Schwerzmann.M et  al found shunt size is  larger in migraine 
with aura patients than control subjects36.           
Anzola and  colleagues  found  the prevalence of  patent foramen ovale 
was  48% in   migraine  with  aura  patients,23% of   migraine  without  aura 
patients and 20% in control subjects4.Domitrz  et al found  the prevalence of 
patent  foramen  ovale  was  53%  in   migraine  with  aura  patients,25%  of 
migraine without aura patients and 20% in control subjects10.Dalla volta G et 
al study showed the patent foramen ovale was present in 61.9% in  migraine 
with aura patients,16.2% of   migraine  without aura  patients  and 36.8% in 
cluster headache patients7.Schwerzmann.M et al found  the patent foramen 
ovale was present in 47% in  migraine with aura patients, and 17%  of control 
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subjects36.But Patent foramen ovale was present in 10% of  migraine with 
aura patients in our study. Patent foramen ovale was not present in any of 
migraine without aura patients in our study.
Atrial septal defect of sinus venosus type was observed only in 5% of 
migraine without aura patients in our study.                  
             We analysed the presence of shunt lesions and severity of MIDAS 
score. MIDAS score was severe in all migraine with aura patients who had 
osteum secundum type of  atrial  septal  defect   and patent  foramen ovale  . 
MIDAS score was moderate in migraine without aura patients who had  sinus 
venosus type of atrial septal defect.
               In migraine with aura patients who had shunt lesion ,closure of the 
shunt  may ameliorate  migraine symptoms  or may  improve by reduction in 
frequency   and     severity 3,5,11,15,29,37,46.In our study one patient with migraine 
with  aura  who  had  osteum  secundum  type  of  atrial  septal  defect,had 
undergone closure of  atrial septal defect.He was followed up prospectively 
for  one year.He was symptom free  after  the  closure.MIDAS Score  before 
closure was 50 and after closure was 2.So,the closure of shunt has a role in 
ameliorating  symptoms  in  patients  with  migraine.However,further  larger 
prospective randomized trials are needed to establish the role of  closure of 
the shunt in managing  migraine patients5,11,37.
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CONCLUSION
1. The female to male ratio in our study was found to be 2.8:1.Female 
predilection  was more in younger age group <35 years.
2. Shunt lesion was present in 34% of migraine with aura patients. But 
only in 5%  of migraine without aura patients.
3. Osteum secundum type of atrial septal defect was found to be the most 
common shunt lesion in our  24% of  migraine with aura patients.
4. Patent foramen ovale was found in 10% of migraine with aura patients.
5. Atrial septal defect of svc type was noticed in only 5% of migraine 
without  aura   patients.
6. Statistically significant number of  migraine with aura patients had 
shunt  lesions.
7. Transesophageal contrast echocardiography is valuable in patients with 
migraine  more so in aura patients  to detect shunt lesions.
8. Closure  of  the  shunt  in  patients  with  migraine  may  ameliorate 
symptoms.
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                            PROFORMA
Name :                                              Age:                         Sex:
  
Address :                                         I.P.No :
                                                               Neuro No :
H/O Headache                    Duration :                       Frequency :
                                            Periodicity :
                                            Unilateral/Bilateral
                           
                                            Quality of pain :             Severity :
                                   
                                            Aggravating factors:
                                            Aura:  yes/no-    
                                            Visual/sensory/Motor/Olfactory/Gustatory
GI Autonomic symptoms:
                                         Nausea :
                                         Vomiting :
                                         Diarhoea :
                                        Abdominal cramps:
Sensory hyperexcitability:
                                        Photophobia:
                                        Phonophobia:                     Osmophobia:
Unilateral cranial autonomic  symptoms :
                                       Lacrimation :
                                       Conjunctival injection
                                       Nasal congestion :
                                        Rhinorhoea :
Systemic:
                                      Faintness :
                                      Fever :
                                      Palpitation :
                                      Anorexia :
                                      Polyuria :
                                      Postural hypotension:
Visual loss : 
Memory loss:
Loss of consciousness:
Fits:
Weakness:                              Sensory loss:
Unsteadiness while walking:
Family history
MIDAS Score:
1. How many days in past 3 months –missed work or school because 
of  your  headache?
2. How many days in past 3 months-productivity at work or school 
reduced by half  or more because of your headache?
3. How many days in past 3 months-not do household work because 
of  your   headache?
4. How many days in past 3 months-productivity at household work 
reduced by half or more because of your headache?
5. How many days in past 3 months-did you  miss family ,social or 
non  work activities because of your headache?
       A. On how many days in the past 3 months did you have a headache?
 
       B.  On a scale of 0-10,how painful were these headache on average?
       Total MIDAS Score-
  
       MIDAS Grade-
      (Grade1minimal/frequent  -score  0-5,mild  II-6-10,moderate 
III-11-20,severe IV-21+-  Sum of lost days due to headache for  questions 
1-5)
Any systemic disease:Diabetes mellitus/Hypertension
Medication use
Complete hemogram:
ESR :
ANA :                                             
 RA Factor :
CT Scan Brain:
ECG :
Transesophageal contrast echocardiography:       
